Chengfu Xu
Overview
Explore the profile of Chengfu Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
134
Citations
2381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shen Q, Xu C
Aliment Pharmacol Ther
. 2025 Feb;
61(7):1268-1269.
PMID: 40019255
No abstract available.
2.
Guo Y, Huang H, Yang L, Shen Q, Liu Z, Wang Q, et al.
J Biol Chem
. 2025 Feb;
301(3):108285.
PMID: 39938799
Metabolic dysfunction-associated steatohepatitis (MASH) is a complicated process that contributes to end-stage liver disease and, eventually, hepatocellular carcinoma. Hepatocyte apoptosis, a well-defined form of cell death in MASH, is considered...
3.
Cai C, Luo H, Peng J, Zhen X, Shen X, Xi X, et al.
Mol Ther
. 2025 Feb;
PMID: 39905730
Metabolic dysfunction-associated steatohepatitis (MASH), a progressive form of metabolic dysfunction-associated fatty liver disease (MAFLD), is a leading cause of liver disease worldwide and can progress to cirrhosis and cancer. Despite...
4.
Shen Q, Xu C
Aliment Pharmacol Ther
. 2024 Oct;
60(11-12):1662-1663.
PMID: 39466008
No abstract available.
5.
Chen S, Xu L, Yan L, Zhang J, Zhou X, Wang J, et al.
Endoscopy
. 2024 Oct;
PMID: 39447610
Background: Autoimmune gastritis (AIG), distinct from Helicobacter pylori-associated atrophic gastritis (HpAG), is underdiagnosed due to limited awareness. This multicenter study aimed to develop a novel endoscopic artificial intelligence (AI) system...
6.
Liu P, Song X, Chen Q, Cen L, Tang C, Yu C, et al.
J Biol Chem
. 2024 Oct;
300(11):107876.
PMID: 39395794
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. Ubiquitin-specific peptidase 25 (USP25) in adipocytes has been proven to be involved in insulin resistance, a noteworthy...
7.
Tao L, Yang X, Ge C, Zhang P, He W, Xu X, et al.
Cell Metab
. 2024 Aug;
36(10):2190-2206.e5.
PMID: 39142286
The complex etiological factors associated with metabolic dysfunction-associated fatty liver disease (MAFLD), including perturbed iron homeostasis, and the unclear nature by which they contribute to disease progression have resulted in...
8.
Risk of incident type 2 diabetes in male NAFLD and NAFLD-free smokers: a 7-year post-cessation study
Xie J, Lin P, Hou L, Miao M, Zhu Z, Li Y, et al.
Diabetol Metab Syndr
. 2024 Aug;
16(1):192.
PMID: 39118126
Background: We aimed to investigate the post-cessation T2DM risk in male NAFLD and NAFLD-free smokers in a 7-year cohort study. Methods: The study population was male adults who underwent annual...
9.
Liu Z, Huang H, Xie J, Xu Y, Xu C
Nat Commun
. 2024 May;
15(1):3707.
PMID: 38697980
Nuclear magnetic resonance (NMR)-based plasma fatty acids are objective biomarkers of many diseases. Herein, we aim to explore the associations of NMR-based plasma fatty acids with the risk of hepatocellular...
10.
Xu M, Lin Y, Yang N, Li J, Li L, Ding H, et al.
Rev Assoc Med Bras (1992)
. 2024 Mar;
70(3):e20230963.
PMID: 38451586
Objective: The aim of this study was to explore the correlation between skeletal muscle content and the presence and severity of metabolic dysfunction-associated fatty liver disease in patients with metabolic...